Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02173938 · ClinicalTrials.gov registry record
Novel Psychosocial Influences on Smoking Cessation
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 61
- Enrollment target
NCT02173938 is a clinical trial that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 61 participants.
The verdict
NCT02173938 has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
Our overall research goal is to determine how these novel psychosocial factors impact cessation. This pilot study will answer how dual use of other tobacco products, direct to consumer marketing, and the new phenomenon of butting-out and relighting influences cessation, and how understanding impulsivity and task persistence could lead to new and improved behavioral interventions for tobacco dependence. Answers to these pilot questions will lead to the publication of several manuscripts and provide important feasibility data to design large, well-powered clinical trials, population-level epidemiological studies, and contribute to furthering the field of tobacco treatment.
Interventions
- OTHER Tobacco Dependence Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02173938
The ClinicalTrials.gov registry entry for NCT02173938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tobacco Dependence Treatment is the first listed.
NCT02173938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02173938 about?
NCT02173938 is a clinical study titled "Novel Psychosocial Influences on Smoking Cessation". Our overall research goal is to determine how these novel psychosocial factors impact cessation. This pilot study will answer how dual use of other tobacco products, direct to consumer marketing, and the new phenomenon of butting-out and relighting influences cessation, and how understanding impulsi...
What is the current status of trial NCT02173938?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2012-08. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02173938?
The interventions under investigation include: Tobacco Dependence Treatment (OTHER).
Who is sponsoring clinical trial NCT02173938?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.